Quick Answer
Silo Pharma, Inc. reported Gross Profit of $27.8 thousand for fiscal year 2025.
Silo Pharma, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $27.8K | -58.0% |
| 2024 | $66.3K | +0.0% |
| 2023 | $66.3K | +0.0% |
| 2022 | $66.3K | +0.0% |
| 2021 | $66.3K | +149.0% |
| 2020 | -$135.2K | -1125.7% |
| 2019 | $13.2K | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$2.7K | -116.1% | -116.1% |
| June 30, 2025 | $16.6K | +0.0% | +0.0% |
| March 31, 2025 | $16.6K | +0.0% | +0.0% |
| September 30, 2024 | $16.6K | +0.0% | +0.0% |
| June 30, 2024 | $16.6K | +0.0% | +0.0% |
| March 31, 2024 | $16.6K | +0.0% | +0.0% |
| September 30, 2023 | $16.6K | +0.0% | +0.0% |
| June 30, 2023 | $16.6K | +0.0% | +0.0% |
- Silo Pharma, Inc. showed a decrease of -58.0% in Gross Profit compared to the prior fiscal year.
- Over the 2019–2025 period, Silo Pharma, Inc.’s gross profit has grown by 110.9% (from $13.2 thousand to $27.8 thousand).
- The most recent figure is from Silo Pharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: